Anti-muscarinic drugs increase rectal compliance and exacerbate constipation in chronic spinal cord injury

[1]  A. Emmanuel,et al.  Altered Colorectal Compliance and Anorectal Physiology in Upper and Lower Motor Neurone Spinal Injury May Explain Bowel Symptom Pattern , 2016, The American Journal of Gastroenterology.

[2]  K. Browning,et al.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. , 2014, Comprehensive Physiology.

[3]  L. Cardozo,et al.  Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability , 2014, Neurourology and urodynamics.

[4]  A. Emmanuel,et al.  Morphological Abnormalities of the Recto-Anal Inhibitory Reflex Reflects Symptom Pattern in Neurogenic Bowel , 2012, Digestive Diseases and Sciences.

[5]  C. Fowler,et al.  Bowel Biofeedback Treatment in Patients With Multiple Sclerosis and Bowel Symptoms , 2011, Diseases of the colon and rectum.

[6]  A. Zinsmeister,et al.  Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects , 2008, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[7]  C. Ausch,et al.  Sacral Nerve Stimulation in Patients with Severe Constipation , 2008, Diseases of the colon and rectum.

[8]  Gary Kay,et al.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder , 2006, British journal of pharmacology.

[9]  S. Rutkowski,et al.  Gastrointestinal Symptoms in Spinal Cord Injury: Relationships With Level of Injury and Psychologic Factors , 2005, Diseases of the colon and rectum.

[10]  P. Abrams,et al.  A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder , 2005, BJU international.

[11]  R. Chess-Williams,et al.  Muscarinic receptor subtypes of the bladder and gastrointestinal tract. , 2004, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[12]  L. Kost,et al.  Model of rapid gastrointestinal transit in dogs: effects of muscarinic antagonists and a nitric oxide synthase inhibitor , 2002, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  M. Michel,et al.  M3 muscarinic receptors mediate contraction of human urinary bladder , 2002 .

[14]  R. Chess-Williams,et al.  The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro. , 2001, Journal of autonomic pharmacology.

[15]  R. Eglen,et al.  Therapeutic opportunities from muscarinic receptor research. , 2001, Trends in pharmacological sciences.

[16]  F. Frizelle,et al.  Bowel dysfunction following spinal cord injury: a description of bowel function in a spinal cord-injured population and comparison with age and gender matched controls , 2000, Spinal Cord.

[17]  S. Laurberg,et al.  Gastrointestinal and segmental colonic transit times in patients with acute and chronic spinal cord lesions , 2000, Spinal Cord.

[18]  W. Whitehead,et al.  AGA technical review on anorectal testing techniques. , 1999, Gastroenterology.

[19]  M. Kamm,et al.  Prospective comparison of faecal incontinence grading systems , 1999, Gut.

[20]  T. Han,et al.  Chronic gastrointestinal problems and bowel dysfunction in patients with spinal cord injury , 1998, Spinal Cord.

[21]  N. Birdsall,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[22]  A. Michell,et al.  MP44-04 IMPORTANCE OF THE ULTRASOUND CHARACTERISTICS OF REGIONS OF INTEREST BY MRI AND THE ADDITIONAL TARGET BIOPSY AROUND THEIR PERI-HYPOECHOIC LESIONS IN MR/TRUS SOFTWARE FUSION BIOPSY TO IMPROVE DETECTION RATE OF PROSTATE CANCER , 2023, Journal of Urology.

[23]  S. Laurberg,et al.  Colorectal function in patients with spinal cord lesions , 1997, Diseases of the colon and rectum.

[24]  R. Eglen,et al.  Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo , 1997, British journal of pharmacology.

[25]  M. Kamm,et al.  Bowel dysfunction in spinal-cord-injury patients , 1996, The Lancet.

[26]  S. Wexner,et al.  A constipation scoring system to simplify evaluation and management of constipated patients , 1996, Diseases of the colon and rectum.

[27]  M. Ruggieri,et al.  Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. , 1995, The Journal of pharmacology and experimental therapeutics.

[28]  R. Gore,et al.  Gastrointestinal Complications of Spinal Cord Injury , 1981, Spine.

[29]  K. Andersson,et al.  Antimuscarinics and the overactive detrusor--which is the main mechanism of action? , 2003, European urology.

[30]  M. Michel,et al.  M(3) muscarinic receptors mediate contraction of human urinary bladder. , 2002, British journal of pharmacology.

[31]  M. Laere,et al.  Constipation and other chronic gastrointestinal problems in spinal cord injury patients , 1998, Spinal Cord.

[32]  S. Wexner,et al.  Etiology and management of fecal incontinence , 1993, Diseases of the colon and rectum.